Compositions and methods relating to novel compounds and targets thereof

Details for Australian Patent Application No. 2008200867 (hide)

Owner The Regents of The University of Michigan

Inventors Opipari, Anthony W.; Glick, Gary D.

Agent Spruson & Ferguson

Pub. Number AU-A-2008200867

Parent 2004255153

Filing date 22 February 2008

Wipo publication date 13 March 2008

International Classifications

A61P 35/00 (2006.01) Antineoplastic agents

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C12N 5/02 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Propagation of single cells or cells in suspension

C12N 7/01 (2006.01) Viruses, e.g. bacteriophages - Viruses, e.g. bacteriophages, modified by introduction of foreign genetic material

Event Publications

13 March 2008 Application Open to Public Inspection

  Published as AU-A-2008200867

13 March 2008 Complete Application Filed

16 October 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008200868-Soluble form of carbonic anhydrase IX (s-CA IX), assays to detect s-CA IX, CA IX's coexpression with HER2/neu/c-erb-B2, and CA IX-specific monoclonal antibodies to nonimmunodominant epitopes

2008200866-Showcase